VANDRIA

Pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging